About Taipei Veterans General Hospital; Department of Oncology
Taipei Veterans General Hospital is a national first-class medical center and a teaching hospital that provides tertiary patient care, undergraduate medical education programs and residency programs in Taiwan. It was founded in 1958 and administered by the Veterans Affairs Council.
Clinical Trials at Taipei Veterans General Hospital; Department of Oncology
During the past decade, Taipei Veterans General Hospital; Department of Oncology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei Veterans General Hospital; Department of Oncology"
#1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "National Tsing Hua University,Taiwan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Taipei Veterans General Hospital; Department of Oncology
According to Clinical.Site data, the most researched conditions in "Taipei Veterans General Hospital; Department of Oncology" are
"ALS (Amyotrophic Lateral Sclerosis)" (1 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "B-cell Lymphoma" (1 trials), "Biliary Tract Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Taipei Veterans General Hospital; Department of Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Taipei Veterans General Hospital; Department of Oncology
Most popular intervention types in "Taipei Veterans General Hospital; Department of Oncology" are "Drug" (9 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (5 trials), "Bevacizumab" (3 trials), "Placebo" (3 trials), "Tiragolumab" (3 trials) and "Atezolizumab Matching Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Taipei Veterans General Hospital; Department of Oncology
The vast majority of trials in "Taipei Veterans General Hospital; Department of Oncology" are
12 trials for "All" genders.
Clinical Trials Status at Taipei Veterans General Hospital; Department of Oncology
Currently, there are NaN active trials in "Taipei Veterans General Hospital; Department of Oncology".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Taipei Veterans General Hospital; Department of Oncology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Taipei Veterans General Hospital; Department of Oncology, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".